SCM LifeScience Co

SCM LifeScience Co Net Tangible Assets

The Net Tangible Assets of SCM LifeScience Co (298060.KQ) as of Nov 19, 2026 is 32.47 B KRW. In the previous year, Net Tangible Assets was 13.48 B KRW — a change of 140.81% (higher).

Net Tangible Assets

32.47 BKRW

YoY

140.81%

Last updated:

Net Tangible Assets of SCM LifeScience Co is 2025 32.47 B KRW. Net Tangible Assets of SCM LifeScience Co was 2024 13.48 B KRW. It decreases by 140.81% higher compared to the previous year.

The SCM LifeScience Co Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
-45.00 B KRW
Jan 1, 2019
16.47 B KRW
Jan 1, 2020
62.72 B KRW
Jan 1, 2021
44.28 B KRW
Jan 1, 2022
24.21 B KRW
Jan 1, 2023
20.24 B KRW
Jan 1, 2024
13.48 B KRW
Jan 1, 2025
32.47 B KRW
The SCM LifeScience Co Net Tangible Assets history
YEARNet Tangible AssetsYoY
32.47 BKRW+140.81%
13.48 BKRW-33.37%
20.24 BKRW-16.41%
24.21 BKRW-45.33%
44.28 BKRW-29.41%
62.72 BKRW+280.71%
16.47 BKRW-136.61%
-45.00 BKRW+417.51%
-8.69 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCM LifeScience Co Stock analysis

What does SCM LifeScience Co do? SCM LifeScience Co Ltd is a biotechnology company headquartered in Incheon, South Korea. The company focuses on the development and production of cell therapy products, including adult stem cell therapies. It also engages in agency testing for cell production and quality assurance, as well as providing adult stem cell consulting services. Additionally, SCM LifeScience operates in the cosmetics and hair growth protein manufacturing sectors. The company has 55 full-time employees. SCM LifeScience completed its initial public offering (IPO) on June 17, 2020. Its stock is listed under the ticker 298060.KQ on the Korean stock exchange, with an ISIN code of KR7298060005. The company's website is http://www.scmlifescience.com/. SCM LifeScience operates within the healthcare sector, specifically within the biotechnology industry. It does not provide details on its founding year, specific product names, or financial figures beyond the IPO date and employee count. The company's activities span drug development for stem cell therapy, cell production testing, and manufacturing of related products. SCM LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCM LifeScience Co stock

Net Tangible Assets of SCM LifeScience Co is 32.47 B KRW in 2025.

Net Tangible Assets of SCM LifeScience Co changed from 13.48 B KRW to 32.47 B KRW, representing a 140.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets SCM LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's SCM LifeScience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SCM LifeScience Co

All Key Metrics — SCM LifeScience Co